WCM Investment Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Sell
359,761
-12,921
-3% -$441K 0.02% 145
2025
Q4
$15M Buy
372,682
+46,961
+14% +$1.72M 0.03% 127
2025
Q3
$11.4M Sell
325,721
-1,777
-0.5% -$61.2K 0.02% 137
2025
Q2
$10.6M Buy
327,498
+134,146
+69% +$4.36M 0.02% 144
2025
Q1
$6.15M Buy
193,352
+1,551
+0.8% +$57.6K 0.02% 161
2024
Q4
$5.8M Sell
191,801
-23,785
-11% -$765K 0.01% 172
2024
Q3
$6.08M Sell
215,586
-8,417
-4% -$207K 0.01% 164
2024
Q2
$5.22M Buy
224,003
+1,160
+0.5% +$26.8K 0.01% 162
2024
Q1
$6.78M Buy
222,843
+1,427
+0.6% +$47.8K 0.02% 151
2023
Q4
$8.13M Buy
221,416
+15,820
+8% +$588K 0.02% 150
2023
Q3
$9.01M Buy
205,596
+3,528
+2% +$172K 0.03% 135
2023
Q2
$9.97M Buy
202,068
+12,205
+6% +$563K 0.03% 137
2023
Q1
$7.87M Buy
189,863
+269
+0.1% +$11.2K 0.03% 144
2022
Q4
$8.41M Sell
189,594
-2,653
-1% -$111K 0.03% 140
2022
Q3
$7.6M Buy
192,247
+6,774
+4% +$310K 0.03% 133
2022
Q2
$7.56M Sell
185,473
-88
-0% -$4.17K 0.03% 139
2022
Q1
$12.2M Buy
185,561
+65,506
+55% +$4.24M 0.03% 115
2021
Q4
$8.35M Buy
120,055
+6,641
+6% +$483K 0.02% 139
2021
Q3
$7.89M Sell
113,414
-44,938
-28% -$3.46M 0.02% 137
2021
Q2
$12.6M Buy
158,352
+6,207
+4% +$451K 0.03% 94
2021
Q1
$9.97M Sell
152,145
-3,176
-2% -$196K 0.03% 111
2020
Q4
$8.65M Buy
155,321
+482
+0.3% +$20.8K 0.02% 124
2020
Q3
$6.18M Buy
154,839
+3,994
+3% +$169K 0.02% 126
2020
Q2
$6.78M Buy
150,845
+13,150
+10% +$573K 0.03% 113
2020
Q1
$4.63M Buy
137,695
+39,559
+40% +$1.42M 0.03% 111
2019
Q4
$3.19M Buy
98,136
+74,893
+322% +$2.13M 0.02% 135
2019
Q3
$580K Sell
23,243
-23,683
-50% -$676K ﹤0.01% 138
2019
Q2
$1.4M Buy
46,926
+17,248
+58% +$504K 0.01% 103
2019
Q1
$795K Buy
+29,678
New +$901K 0.01% 124

Other funds holding ATRC

WCM Investment Management's ATRC Position: Q1 2026 in Review

WCM Investment Management reduced its AtriCure (ATRC) stake by 3.5% in Q1 2026, selling an estimated $441K and leaving 359,761 shares worth $10.2M. The position accounts for 0.02% of the portfolio, ranked #145.

WCM Investment Management first reported a position in ATRC in Q1 2019 and has held it in 29 quarters since. The position peaked at $15M in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • WCM Investment Management held 359,761 shares of AtriCure worth $10.2M as of Q1 2026.
  • WCM Investment Management sold 12,921 AtriCure shares in Q1 2026, an estimated $441K.
  • AtriCure made up 0.02% of WCM Investment Management's portfolio in Q1 2026, its #145 holding.
  • WCM Investment Management first reported a position in AtriCure in Q1 2019 and has held it in 29 quarters since.
  • WCM Investment Management's AtriCure position peaked at $15M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.